Denovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating Psychosis

Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced a partnership with Orygen to initiate a Phase 2 investigator-initiated-trial (IIT) to ...

DifGen Pharmaceuticals LLC Receives USFDA Approval for Fluorometholone Ophthalmic Suspension, 0.1% - Expanding Its Complex Generic Portfolio

DifGen Pharmaceuticals, a leading US based generic pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (USFDA) for its Fluorometholone ...

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to …

ESTERO, FLORIDA / ACCESS Newswire / February 11, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
Nasdaq

Denovo Biopharma LLC Announces Partner Aytu BioPharma Receives FDA Clearance and Orphan Drug Designation for Enzastaurin in Vascular Ehlers-Danlos Syndrome

SAN DIEGO, Dec. 14, 2021 /PRNewswire/ -- Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, today announced its partner Aytu ...
Business Wire

Onxeo to Receive $6.6 Million by Granting Additional Exclusive Rights to Belinostat to Acrotech Biopharma LLC

PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative ...
Benzinga.com

ALTA BIOPHARMA MANAGEMENT III LLC's Net Worth

Who is ALTA BIOPHARMA MANAGEMENT III LLC? ALTA BIOPHARMA MANAGEMENT III LLC has an estimated net worth of $96.6 Million. This is based on reported shares across multiple companies, which include ...
Benzinga.com

ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC

ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC owns 5,832,065 units of Common Stock which is worth $125,447,718.15. From 2007 to 2009 ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC acquired a total of 804,128 ...
Nasdaq

Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC

MELBOURNE, Fla., Feb. 29, 2024 /PRNewswire/ -- Branded Legacy (OTC.PK: BLEG), Inc., a leading BioTech holdings company, announced today the signed letter of intent to purchase Sycamore BioPharma, LLC, ...

Kingsway Pharmaceuticals Welcomes Lobe Miracle(R) to Its Family of Trusted Brands

Kingsway Pharmaceuticals, LLC announced today that it has officially acquired the Lobe Miracle(R) brand from CCA Industries, Inc., marking a significant step in the company's continued expansion ...
Emirates 24/7

Adam Vital Hospital Announces Strategic Partnership with Siemens Healthineers and Modern Pharmaceutical LLC (MPC) to Build Next-Generation AI-Driven Diagnostic Infrastructure ...

Adam Vital Hospital has announced the signing of a Memorandum of Understanding (MoU) with Siemens Healthineers, in collaboration with Modern Pharmaceutical LLC (MPC). The MoU marks the start of a stra ...
KRQE Blogs

Denovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision Medicine

ENLIGHTEN, a genetic biomarker–guided global late–stage clinical trial of DB104 (liafensine) for treatment–resistant depression, successfully met all major study endpoints SAN DIEGO, April 3, 2024 ...
Morningstar

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Defendants repeatedly entered thousands of ...